175 related articles for article (PubMed ID: 38212344)
21. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis.
Cheung CC; Chung GT; Lun SW; To KF; Choy KW; Lau KM; Siu SP; Guan XY; Ngan RK; Yip TT; Busson P; Tsao SW; Lo KW
Mol Cancer; 2014 Aug; 13():184. PubMed ID: 25098679
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
Wu J; Tang Q; Zhao S; Zheng F; Wu Y; Tang G; Hahn SS
Int J Oncol; 2014 Jul; 45(1):95-103. PubMed ID: 24806432
[TBL] [Abstract][Full Text] [Related]
23. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
[TBL] [Abstract][Full Text] [Related]
24. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
25. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
26. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
[TBL] [Abstract][Full Text] [Related]
27. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
28. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression.
Hou R; Liu X; Yang H; Deng S; Cheng C; Liu J; Li Y; Zhang Y; Jiang J; Zhu Z; Su Y; Wu L; Xie Y; Li X; Li W; Liu Z; Fang W
Cancer Lett; 2022 Apr; 531():57-70. PubMed ID: 35114328
[TBL] [Abstract][Full Text] [Related]
29. Circadian clock gene
Zhao C; Meng X; Li Y; Liu L; He Q; Jiang J; Chen Y; Li X; Li Y; Tang Y; Zhou D; Zhou J; Jin F
Chronobiol Int; 2022 Oct; 39(10):1340-1351. PubMed ID: 35903031
[No Abstract] [Full Text] [Related]
30. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
[TBL] [Abstract][Full Text] [Related]
31. CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells.
Ge Y; Long Y; Xiao S; Liang L; He Z; Yue C; Wei X; Zhou Y
Int J Oncol; 2019 Feb; 54(2):585-599. PubMed ID: 30535454
[TBL] [Abstract][Full Text] [Related]
32. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
[No Abstract] [Full Text] [Related]
33. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
[TBL] [Abstract][Full Text] [Related]
34. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q
Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067
[TBL] [Abstract][Full Text] [Related]
35. MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma.
Fan X; Wang Y; Song J; Wu H; Yang M; Lu L; Weng X; Liu L; Nie G
Cancer Biol Ther; 2019; 20(10):1328-1336. PubMed ID: 31311404
[TBL] [Abstract][Full Text] [Related]
36. Galectin‑3 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma.
Li M; Chen YB; Liu F; Qu JQ; Ren LC; Chai J; Tang CE
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760180
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma.
Chen C; Ren A; Yi Q; Cai J; Khan M; Lin Y; Huang Z; Lin J; Zhang J; Liu W; Xu A; Tian Y; Yuan Y; Zheng R
Clin Exp Immunol; 2023 Jul; 213(2):221-234. PubMed ID: 37249005
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
39. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
Jiang L; Wang P; Chen L; Chen H
Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
